Skip to main content
. 2018 Aug 3;4:36. doi: 10.1186/s40798-018-0149-9

Table 3.

Excluded studies from meta-analysis due to confounding factors

Study N Age, years (mean ± SD) Duration Testing modality Sets (reps) Days trained per week Frequency per week Pre- vs. post-intervention kg,
mean ± SD
Pre- vs. post-intervention
strength difference
kg (% change)
p value (pre vs. post) ES
Gomes et al. [20] 12
11
25.5 (± 1.25)
27.1 (± 1.85)
8 weeks Sq 5–10 (8–12) 1
5
LF
HF
132.9 ± 28.0 vs. 140.9 ± 25.5
123.3 ± 17.5 vs. 135.3 ± 22.2
8 (6.02)
12 (9.73)
0.47
0.17
0.30
0.60
Gomes et al. [20] 12
11
25.5 (± 1.25)
27.1 (± 1.85)
8 weeks BP 5–10 (8–12) 1
5
LF
HF
103.5 ± 15.4 vs. 109.1 ± 18.5
100.6 ± 14.5 vs. 110.3 ± 12.1
5.6 (5.41)
9.7 (9.64)
0.43
0.10
0.33
0.73
Serra et al. [21] 26
32
16
35.3 (± 1.75)
34 (± 2)
34.85 (± 0.85)
3 months WG PullD 3 (10–20) 2
3
4
MF
HF
HF
42.6 ± 20.7 vs. 48.5 ± 20.7
44.4 ± 13.9 vs. 51.3 ± 13.9
40.6 ± 20.3 vs. 48.6 ± 21.8
5.9 (13.8)
6.9 (13.5)
8 (16.5)
≤ 0.001 a
≤ 0.001a
≤ 0.001a
0.29
0.50
0.38
Serra et al. [21] 26
32
16
35.3 (± 1.75)
34 (± 2)
34.85 (± 0.85)
3 months CP 3 (10–20) 2
3
4
MF
HFe
HF
41.2 ± 25.6 vs. 49.9 ± 30.2
46.6 ± 20.8 vs. 59.7 ± 25.1
42.1 ± 27.9 vs. 55.6 ± 36.2
8.7 (21.1)
13.1 (28.1)
13.5 (32.1)
≤ 0.001a
≤ 0.001a
≤ 0.00a
0.31
0.57
0.42
Serra et al. [21] 26
32
16
35.3 (± 1.75)
34 (± 2)
34.85 (± 0.85)
3 months LP 3 (10–20) 2
3
4
MF
HFe
HF
108.9 ± 49.1 vs. 128.9 ± 54.5
120.2 ± 48.0 vs. 149.0 ± 57.7
128.8 ± 55.4 vs. 168.1 ± 89.0
20 (18.4)
28.8 (24.0)
39.3 (30.5)
≤ 0.001a
≤ 0.001a
≤ 0.001a
0.39
0.54
0.53
Yue et al. [23] 9
9
28 (± 7.9)
21 (± 3.2)
6 weeks Sq 4 (8–12)
2 (8–12)
2
4
MF
HF
103 ± 27 vs. 115 ± 34
90 ± 9 vs. 103 ± 13
12 (11.7)
13 (14.4)
≤ 0.001a
≤ 0.001a
0.39
1.16
Yue et al. [23] 9
9
28 (± 7.9)
21 (± 3.2)
6 weeks BP 4 (8–12)
2 (8–12)
2
4
MF
HF
77 ± 27 vs. 88 ± 30
70 ± 17 vs. 81 ± 15
11 (14.3)
11 (15.7)
≤ 0.001a
≤ 0.001a
0.39
0.69
Carpenter et al. [34] 10
12
12
7
31(± 31) 20 weeks LumExt 1 (8–12) 0.5
2
3
4
LF
MF
HF
HF
73.6 ± 24.7 vs. 98.2 ± 32.8
58.9 ± 18.0 vs. 86.2 ± 28.0
69.9 ± 27.5 vs. 105.9 ± 40.8
78.2 ± 21.4 vs. 115.8 ± 31.3
24.6 (33.4)
27.3 (46.3)
36 (51.5)
37.6 (48.1)
≤ 0.05b
≤ 0.05b
≤ 0.05b
≤ 0.05b
0.85
1.16
1.03
1.40
Pollock et al. [35] 14
19
26 (± 9)
30 (± 9)
12 weeks CervExt 1 (8–12) 1
2
LF
MF
28.3 ± 6.7 vs. 38.2 ± 7.8
27.4 ± 8.5 vs. 38.2 ± 10.9
9.9 (35.0)
10.8 (40.9)
0.001a
0.002b
1.36
1.10
Taaffe et al. [40] 11
12
11
68.5 (± 3.6)
69.4 (± 3.0)
71.0 (± 4.1)
24 weeks LPull 3 (8) 1
2
3
LF
MF
HF
36.0 ± 14.2 vs. 45.3 ± 4.31
35.8 ± 9.7 vs. 47.0 ± 4.20
33.6 ± 10.9 vs. 48.9 ± 4.31
9.3 (25.83)
11.2 (31.28)
15.3 (45.54)
≤ 0.001a
≤ 0.001a
≤ 0.001a
0.89
1.50
1.85
Taaffe et al. [40] 11
12
11
68.5 (± 3.6)
69.4 (± 3.0)
71.0 (± 4.1)
24 weeks BC 3 (8) 1
2
3
LF
MF
HF
16.5 ± 7.1 vs. 21.9 ± 2.99
17.0 ± 4.3 vs. 24.4 ± 2.77
16.7 ± 6.2 vs. 23.2 ± 2.99
5.4 (32.73)
7.4 (43.53)
6.5 (38.92)
≤ 0.001a
≤ 0.001a
≤ 0.001a
0.99
2.05
1.34
Taaffe et al. [40] 11
12
11
68.5 (± 3.6)
69.4 (± 3.0)
71.0 (± 4.1)
24 weeks BExt 3 (8) 1
2
3
LF
MF
HF
62.3 ± 24.5 vs. 83.1 ± 9.17
63.4 ± 11.3 vs. 84.2 ± 9.70
65.0 ± 26.5 vs. 84.4 ± 9.29
20.8 (33.39)
20.8 (32.81)
19.4 (29.85)
≤ 0.001a
≤ 0.001a
≤ 0.001a
1.12
1.98
0.98
Taaffe et al. [40] 11
12
11
68.5 (± 3.6)
69.4 (± 3.0)
71.0 (± 4.1)
24 weeks LP 3 (8) 1
2
3
LF
MF
HF
109.5 ± 29.8 vs. 135.2 ± 12.27
113.3 ± 19.3 vs. 142.8 ± 12.47
110.5 ± 29.5 vs. 145.1 ± 3.7
25.7 (23.47)
29.5 (26.04)
34.6 (31.31)
≤ 0.001a
≤ 0.001a
≤ 0.001a
1.13
1.82
1.65
Taaffe et al. [40] 11
12
11
68.5 (± 3.6)
69.4 (± 3.0)
71.0 (± 4.1)
24 weeks KExt 3 (8) 1
2
3
LF
MF
HF
39.3 ± 15.4 vs. 67.1 ± 10.95
43.2 ± 8.6 vs. 72.6 ± 10.74
42.4 ± 12.4 vs. 62.6 ± 10.61
27.8 (70.74)
29.4 (68.06)
20.2 (47.64)
≤ 0.001a
≤ 0.001a
≤ 0.001a
2.08
3.02
1.75
Taaffe et al. [40] 10
12
11
68.5 (± 3.6)
69.4 (± 3.0)
71.0 (± 4.1)
24 weeks KFlex 3 (8) 1
2
3
LF
MF
HF
16.3 ± 7.5 vs. 28.4 ± 4.43
19.6 ± 6.8 vs. 30.4 ± 4.50
20.0 ± 9.4 vs. 28.5 ± 4.64
12.1 (74.23)
10.8 (55.10)
8.5 (42.50)
≤ 0.001a
≤ 0.001a
≤ 0.001a
1.96
1.87
1.15
Farinatti et al. [41] 10
11
10
72 (± 5.0)
66 (± 7.0)
68 (± 4.0)
16 weeks DumBP 1 (8–12) 1
2
3
LF
MF
HF
8.2 ± 1.8 vs. 13.0 ± 2.0
9.6 ± 2.2 vs. 14.4 ± 5.2
10.4 ± 0.9 vs. 15.6 ± 1.7
4.8 (58.54)
4.8 (50.0)
5.2 (50.0)
≤ 0.01a
≤ 0.01a
≤ 0.01a
2.52
1.20
3.82
Farinatti et al. [41] 10
11
10
72 (± 5.0)
66 (± 7.0)
68 (± 4.0)
16 weeks DCur 1 (8–12) 1
2
3
LF
MF
HF
7.8 ± 1.5 vs. 12.2 ± 2.3
8.4 ± 1.7 vs. 13.6 ± 2.6
9.2 ± 1.8 vs. 15.6 ± 0.9
4.4 (56.41)
5.2 (61.90)
6.4 (69.57)
≤ 0.01a
≤ 0.01a
≤ 0.01a
2.27
2.37
4.50
Farinatti et al. [41] 10
11
10
72 (± 5.0)
66 (± 7.0)
68 (± 4.0)
16 weeks KExt 1 (8–12) 1
2
3
LF
MF
HF
18.0 ± 3.7 vs. 25.6 ± 3.2
19.2 ± 4.6 ± 29.6 ± 7.4
19.8 ± 4.9 vs. 32.0 ± 6.8
7.6 (42.22)
10.4 (54.17)
12.2 (61.62)
≤ 0.01a
≤ 0.01a
≤ 0.01a
2.20
1.69
2.06
Farinatti et al. [42] 10
11
10
72 (± 5.0)
66 (± 7.0)
68 (± 4.0)
16 weeks StCR 1 (8–12) 1
2
3
LF
MF
HF
12.0 ± 2.0 vs. 16.8 ± 1.9
12.2 ± 3.0 vs. 17.0 ± 3.7
11.8 ± 0.5 vs. 16.8 ± 1.5
4.8 (40.0)
4.8 (39.34)
5.0 (42.37)
≤ 0.01a
≤ 0.01a
≤ 0.01a
2.46
1.43
4.47
Burt et al. [42] 10
11
Students 8 weeks. LP 1 (6–10) 1
2
LF
MF
263.31 ± 37.23 vs. 362.65 ± 51.06
244.89 ± 45.80 vs. 391.53 ± 45.18
99.34 (99.34)
146.64 (59.9)
≤ 0.0001a
≤ 0.0001a
2.22
3.22
Serra et al. [67] 18
17
10
41.4 (± 9.9) 4 months
8 months
BP 3 (10–12) 2
3
4
MF
HF
HF
41.7 ± 16.4 vs. 57.4 ± 15.4
38.8 ± 16.3 vs. 59.5 ± 16.5
39.0 ± 16.1 vs. 62.8 ± 18.1
36.3 (37.6)
46.5 (53.4)
65.1 (61.0)
0.01a
0.001a
0.01a
0.99
1.26
1.39
Serra et al. [67] 18
17
10
41.4 (± 9.9) 4 months
8 months
LP 3 (10–12) 2
3
4
MF
HF
HF
83.3 ± 21.4 vs. 113.3 ± 26.6
88.2 ± 21.9 vs. 112.5 ± 18.5
80.0 ± 25.4 vs. 117.8 ± 30.5
30.4 (36.01)
32.4 (27.6)
45.4 (47.3)
0.001a
≤ 0.001a
0.01a
1.24
1.20
1.35
Serra et al. [67] 18
17
10
41.4 (± 9.9) 4 months
8 months
LPull 3 (10–12) 2
3
4
MF
HF
HF
50.1 ± 12.0 vs. 67.4 ± 12.0
52.2 ± 12.8 vs. 69.7 ± 17.0
54.5 ± 16.2 vs. 77.5 ± 18.1
29.4 (34.5)
32.0 (33.5)
46.0 (42.2)
0.0001a
0.002a
0.01a
1.44
1.16
1.34
Benton et al. [36] 11
10
47.6 (± 1.2) 8 weeks CP 3–6 (8–12) 3
4
HF
HF
37.4 ± 2.5 vs. 50.0 ± 3.5
44.5 ± 3.0 vs. 59.7 ± 4.1
12.6 (34.0)
15.2 (34.2)
≤ 0.001a
≤ 0.001a
1.25
1.34
Benton et al. [36] 11
10
47.6 (± 1.2) 8 weeks LP 3–6 (8–12) 3
4
HF
HF
105.1 ± 9.8 vs. 135.7 ± 16.7
119.7 ± 11.5 vs. 178.6 ± 19.6
30.6 (29.1)
58.9 (49.2)
≤ 0.001a
≤ 0.001a
0.67
1.16
Ribeiro et al. [37] 5
5
26.7 (± 2.7) 4 weeks BP 4 (6–20) 4
6
HF
HF
104.4 ± 19.3 vs. 113.2 ± 23.0
105.6 ± 16.4 vs. 117.6 ± 16.3
8.8 (8.4)
12 (11.4)
0.53
0.28
0.41
0.73
Hoffman et al. [38] 12
15
23
11
19.7 ± (1.4)
20.1 ± (1.5)
20.1 ± (1.1)
19.7 ± (1.1)
10 weeks. BP 1–5 (2–10) 3
4
5
6
HF
HF
HF
HF
107.2 ± 11.6 vs. 109.1 ± 28.7
127.7 ± 13.9 vs. 132.2 ± 14.5
131.1 ± 20.1 vs. 135.3 ± 19.0
143.9 ± 12.0 vs. 149.7 ± 17.3
1.9 (1.8)
4.5 (3.5)
4.2 (3.2)
5.8 (4.0)
0.83
0.39
0.47
0.37
0.09
0.32
0.21
0.39
Hoffman et al. [38] 12
15
23
11
19.7 ± (1.4)
20.1 ± (1.5)
20.1 ± (1.1)
19.7 ± (1.1)
10 weeks. Sq 1–5 (2–10) 3
4
5
6
HF
HF
HF
HF
140.1 ± 18.6 vs. 147.4 ± 38.9
173.6 ± 36.2 vs. 186.3 ± 31.9
170.6 ± 19.4 vs. 183.4 ± 22.1
191.6 ± 34.9 vs. 204.1 ± 39.5
7.3 (5.2)
12.7 (7.3)
12.8 (7.5)
12.5 (6.5)
0.56
0.32
0.04a
0.44
0.24
0.37
0.62
0.34
Padilha et al. [43] 13
14
68.9 (± 5.0)
66.7 (± 13.9)
12 weeks CP 1 (10–15) 2
3
MF
HF
35.7 ± 6.6 vs. 42.2 ± 8.0
37.1 ± 3.8 vs. 47.3 ± 4.6
6.5 (18.2)
10.2 (27.5)
≤ 0.05b
≤ 0.05b
0.89
2.42
Padilha et al. [43] 13
14
68.9 (± 5.0) 12 weeks LE 1 (10–15) 2
3
MF
HF
41.3 ± 9.3 vs. 48.9 ± 9.1
46.1 ± 10.5 vs. 53.8 ± 12.5
7.6 (18.4)
7.7 (16.7)
≤ 0.05b
≤ 0.05b
0.83
0.67
Padilha et al. [43] 13
14
66.7 (± 13.9) 12 weeks BC 1 (10–15) 2
3
MF
HF
17.0 ± 3.3 vs. 23.4 ± 3.8
17.7 ± 2.5 vs. 24.2 ± 3.6
6.4 (37.6)
6.5 (26.9)
≤ 0.05b
≤ 0.05b
1.80
2.10
Hunter [39] 14
10
22.2 (± 2.2) c 7 weeks BP 2–3 (7–10) 3
4
HF
HF
69.1 ± 22.08 vs. 77.3 ± 20.58
59.3 ± 25.93 vs. 69.20 ± 25.61
8.2 (11.9)
9.9 (16.7)
0.32
0.40
0.38
0.38
Hunter [39] 11
11
23.1 (± 0.9) d 7 weeks BP 2–3 (7–10) 3
4
HF
HF
26.1 ± 5.97 vs. 31.3 ± 6.30
27.3 ± 7.30 vs. 36.40 ± 7.96
5.2 (19.9)
9.1 (33.3)
0.32
≤ 0.05b
0.85
1.19

Abbreviations: N number of subjects, SD standard deviation, reps repetitions; per week number of days trained per week, ES effect size, Sq squat, LF low frequency (1 day per week), MF medium frequency (2 days per week), HF high frequency (≥ 3 day per week), BP bench press, WGPullD wide grip pulldown, CP chest press, LP leg press, LumExt lumbar extension, CervExt cervical extension, LPull lateral pulldown, BC bicep curl, BExt back extension, LP leg press, KExt knee extension, KFlex knee flexion, DumBP dumbbell bench press, DCurl dumbbell curl, StCR standing calf raise

aSignificantly greater than prior to training (p ≤ 0.01)

bSignificantly greater than prior to training (p ≤ 0.05)

cMale-only subjects

dFemale-only subjects